|
Reference | Significant difference | No significant difference | Notes |
|
Alcantara et al. | SBTS: reduced anastomotic leak rate and overall morbidity for SBTS | Mortality, median hospital stay, SSI | Trial stopped prematurely |
|
Arezzo et al. | SBTS: decreased stoma rate, increased total length of stay | Morbidity, median operative time, oncologic outcome at 36 months | |
|
Cheung et al. | SBTS: reduced anastomotic leak rate and stoma rate, increased rate of one-stage procedure | Median cumulative hospital stay, chest infection, intra-abdominal sepsis | |
|
Ghazal et al. | SBTS: reduced mean operative time, necessity of blood and FFP transfusion, SSI | Median total length of stay | |
|
Ho et al. | SBTS: reduced need for intraoperative bowel decompression | Mortality, morbidity, median operative time, medial total length of stay | |
|
Pirlet et al. | | In-hospital mortality, morbidity, stoma rate, anastomotic leak | Trial stopped prematurely |
|
van Hooft et al. | SBTS: reduced initial stoma rate but increased stoma-related complications and increased morbidity at 30 days (interim analysis) | Global health status, mortality | Trial stopped prematurely |
|